Illumina provides tools and services to analyze genetic material with life science and clinical lab applications... Show more
ILMN saw its Momentum Indicator move below the 0 level on January 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In of the 93 cases, the stock moved further down in the following days. The odds of a decline are at .
The 10-day RSI Indicator for ILMN moved out of overbought territory on January 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for ILMN turned negative on January 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .
ILMN moved below its 50-day moving average on February 03, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ILMN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ILMN advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .
ILMN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 181 cases where ILMN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. ILMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.688) is normal, around the industry mean (12.114). P/E Ratio (30.365) is within average values for comparable stocks, (121.202). Projected Growth (PEG Ratio) (0.617) is also within normal values, averaging (1.874). ILMN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (4.975) is also within normal values, averaging (12.571).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ILMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
a manufacturer of integrated systems for the analysis of genetic variation and function
Industry MedicalSpecialties
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TILL | 16.73 | 0.16 | +0.97% |
| Teucrium Agricultural Str No K-1 ETF | |||
| WXET | 16.00 | 0.09 | +0.59% |
| Teucrium 2x Daily Wheat ETF | |||
| SRVR | 30.59 | 0.10 | +0.32% |
| Pacer Data & Infrastructure Rl EsttETF | |||
| XSMO | 77.32 | 0.02 | +0.03% |
| Invesco S&P SmallCap Momentum ETF | |||
| PSMD | 32.69 | -0.04 | -0.13% |
| Pacer Swan SOS Moderate (January) ETF | |||
A.I.dvisor indicates that over the last year, ILMN has been closely correlated with A. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if ILMN jumps, then A could also see price increases.
| Ticker / NAME | Correlation To ILMN | 1D Price Change % | ||
|---|---|---|---|---|
| ILMN | 100% | -2.54% | ||
| A - ILMN | 70% Closely correlated | +1.15% | ||
| TMO - ILMN | 66% Loosely correlated | +0.55% | ||
| MTD - ILMN | 65% Loosely correlated | +0.90% | ||
| RVTY - ILMN | 64% Loosely correlated | -1.57% | ||
| BRKR - ILMN | 60% Loosely correlated | -1.22% | ||
More | ||||